Literature DB >> 7534144

Regulation of insulin-like growth factor binding protein-1 (IGFBP-1) in insulin-dependent diabetes mellitus. Effects of hyperglycaemia and insulin.

J Fowelin1, S Attvall, H von Schenck, U Smith, I Lager, K Hall.   

Abstract

The aim of the present study was to characterize the effect of 44 h of hyperglycaemia on diurnal levels of insulin-like growth factor binding protein-1 (IGFBP-1), insulin-like growth factor-1 (IGF-1), growth hormone (GH) and glucagon in 7 well-controlled subjects with insulin-dependent diabetes mellitus (IDDM). Hyperglycaemia (approximately 15 mmol/l) was induced by a glucose infusion, while the degree of insulinisation was similar to that of a corresponding period with near normoglycaemia (approximately 6.9 mmol/l). Hyperglycaemia for 44 h did not alter the normal diurnal IGFBP-1 levels when the degree of insulinisation was unchanged. The diurnal secretion pattern of IGFBP-1 was preserved in both genders and without any difference between the control and hyperglycaemic periods. However, the IGFBP-1 levels were increased in these IDDM subjects despite a peripheral hyperinsulinemia. An inverse correlation was found between IGFBP-1 and peripheral insulin levels both during periods of rapid changes in IGFBP-1 and insulin concentrations (i.e. morning hours) as well as during the total 24-h sampling period. Total IGF-1 levels were low, but no further decrease was seen after 24 h of hyperglycaemia in the presence of unchanged insulin levels. In conclusion, the present study clearly shows that the increased IGFBP-1 level seen during poor metabolic control in IDDM is not caused by hyperglycaemia. Glucose levels per se do not influence either total IGF-1 or IGFBP-1 concentrations in well-insulinised diabetic patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7534144     DOI: 10.1007/bf00571948

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  20 in total

Review 1.  Insulin-like growth factors and their binding proteins.

Authors:  V R Sara; K Hall
Journal:  Physiol Rev       Date:  1990-07       Impact factor: 37.312

2.  Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein.

Authors:  A M Suikkari; V A Koivisto; E M Rutanen; H Yki-Järvinen; S L Karonen; M Seppälä
Journal:  J Clin Endocrinol Metab       Date:  1988-02       Impact factor: 5.958

3.  Diurnal rhythm of growth hormone-independent binding protein for insulin-like growth factors in human plasma.

Authors:  R C Baxter; C T Cowell
Journal:  J Clin Endocrinol Metab       Date:  1987-09       Impact factor: 5.958

4.  Levels of the small insulin-like growth factor-binding protein are strongly related to those of insulin in prepubertal and pubertal children but only weakly so after puberty.

Authors:  J M Holly; C P Smith; D B Dunger; J A Edge; R A Biddlecombe; A J Williams; R Howell; T Chard; M O Savage; L H Rees
Journal:  J Endocrinol       Date:  1989-05       Impact factor: 4.286

5.  Dose-response characteristics for suppression of low molecular weight plasma insulin-like growth factor-binding protein by insulin.

Authors:  A M Suikkari; V A Koivisto; R Koistinen; M Seppälä; H Yki-Järvinen
Journal:  J Clin Endocrinol Metab       Date:  1989-01       Impact factor: 5.958

6.  Insulin regulates the 35 kDa IGF binding protein in patients with diabetes mellitus.

Authors:  K Brismar; M Gutniak; G Povoa; S Werner; K Hall
Journal:  J Endocrinol Invest       Date:  1988-09       Impact factor: 4.256

7.  Cross-reaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluid.

Authors:  G Póvoa; A Roovete; K Hall
Journal:  Acta Endocrinol (Copenh)       Date:  1984-12

8.  Diabetic autonomic neuropathy. The diagnostic value of heart rate monitoring.

Authors:  J D Mackay; M M Page; J Cambridge; P J Watkins
Journal:  Diabetologia       Date:  1980-06       Impact factor: 10.122

9.  Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

Authors: 
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

10.  Glucagon stimulates insulin-like growth factor binding protein-1 secretion in healthy subjects, patients with pituitary insufficiency, and patients with insulin-dependent diabetes mellitus.

Authors:  A Hilding; K Brismar; M Thorén; K Hall
Journal:  J Clin Endocrinol Metab       Date:  1993-11       Impact factor: 5.958

View more
  1 in total

Review 1.  The endocrine system in diabetes mellitus.

Authors:  Hisham Alrefai; Hisham Allababidi; Shiri Levy; Joseph Levy
Journal:  Endocrine       Date:  2002-07       Impact factor: 3.633

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.